H.C. Wainwright Reiterates Buy Rating, $6 Price Target on Caladrius Biosciences (CLBS)
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $6.00 price target on Caladrius Biosciences (NASDAQ: CLBS), following recent ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
